Summary: Epitestosterone, a Ci 9 -steroid with anti-androgenic activity, was determined in the plasma of 234 boys and men from the ages of 6-86 years, and in the prostate tissue of 15 men 55-82 years of age. It was documented that, while in adulthood the concentration of epitestosterone is about ten times lower than the concentration of testosterone, in the pre-pubertal period the level of epitestosterone is similar or even higher than that of testosterone. In the hyperplastic prostate tissue the content of epitestosterone is comparable to that of androstenedione, it is about twice as high as the content of testosterone and approximately half that of the content of dihydrotestosterone. At least in the case of pre-pubertal boys and in the prostatic tissue it is therefore possible to include epitestosterone into consideration as a regulatory factor for the androgen-dependent events.
Introduction
Epitestosterone, a 17a-epimer of testosterone, was discovered as a mammalian endogenous steroid by Clark & Kochakian in 1947 (1) , and for 40 years it was considered as a biologically totally inactive compound (2) . Certain attention was paid to it as an internal standard in steroid analysis used for the control of testosterone abuse by athletes, and the methodology, based on determining the ratio of testosterone to epitestosterone (3) in the urine, was recognized by the International Olympic Committee in 1987 as the criterion for proving the abuse of testosterone in sports.
In 1987 a short report appeared in dermatological literature on the effect of epitestosterone on the side organ of a golden hamster, in which this steroid inhibited the effect of testosterone on the skin adnexa. Epitestosterone was designated as an anti-androgen, even though the mechanism of this effect was not studied (4).
In our institute, and also in some other laboratories, some of the physiological effects of epitestosterone were therefore studied to elucidate the mechanism of its effect, as is summarized is table 1.
These findings led us to seek the answer to the question as to whether epitestosterone is present in the circulation and tissues of humans in such a concentration to allow its anti-androgenic effects to play some role in hormonal homeostasis. While sufficient facts have been assembled in the literature on the urinary excretion of epitestosterone (5, 25, 26) , data on its concentration in human blood were rare (5) and so far there are none at all on its tissue concentration. Therefore we attempted 1) to ascertain the concentrations of epitestosterone in the blood of boys and men of various age groups, and 2) to find out to what extent the concentration of epitestosterone in the tissue of the hyperplastic prostate can compete with the concentrations of androgens in this secondary sexual gland.
Tab. 1 Some reported effects of epitestosterone
In vivo and in vitro effects Animal Reference rat, mouse
rat (6) rat (6, 19) rat, human (7, 8) l ) 
Materials and Methods
Healthy subjects, patients and blood and tissue sampling
In order to determine the normal concentration of epitestosterone, blood was taken from 156 healthy individuals in the age group 6-65 years, who had been invited by random selection for a survey of iodine deficiency in the district of Usti, as a part of another research project (12) .
We completed the group of elderly men with 78 otherwise healthy men of up to 86 years of age, who had been invited at random into the general practitioner consulting room for prostate-specific antigen screening in another study. The blood was withdrawn from the cubital vein between 8-10 in the morning into heparin coated vials. Not more than 2 h later plasma was separated and stored in a freezer at -20 °C until processed in the laboratory.
The tissue samples of the hyperplastic prostates were obtained from 15 patients who had been operated on in the period October-December 1993 for adenoma of the prostate with transabdominal suprapubic entry at the Urological Clinic of the 1st Medical Faculty of the Charles University in Prague. The patients were between the ages of 55-82 years, the average weight of the dissected gland was 60.5 g. The criteria for exclusion from the group were a former or contemporary medical therapy of hyperplasia of the prostate, hormonal treatment of any type for three months before the operation and defects of the liver metabolism. The tissue removed surgically was examined histologically by a pathologist and stored in a freezer at -20 °C. For details see 1. c. (13) .
Determination of steroids
The tissue steroids were extracted and cleaned according to Scheme 1 by liquid chromatography under the conditions given in detail elsewhere (13) , the plasmatic steroids were determined without Chromatographie purification, the plasma epitestosterone was determined by the extraction technique according to Bilek (5) . The epitestosterone was determined by the original radioimmunological method (5), testosterone, androstenedione and dihydrotestosterone were determined by conventional radioimmunoassay (14) (15) (16) . For the method of steroid determination in prostatic tissue the recovery was checked by spiking with 500 pg of each steroid per g of tissue.
The recovery was 88.2%, 89.1%, 93.0%, and 115%, respectively for androstenedione, testosterone, epitestosterone and dihydrotestosterone.
Statistical analysis
The values are given as arithmetical average ± SEM and median ± standard deviation of median. The t-test for different group variances was used for inter-group comparison. Partly the linearized regression was carried out by the method of weighted least squares, partly the stepwise polynomial regression for constants of polynomials lying on the level of probability p < 0.05 was performed.
The statistical significance of the correlation coefficients was determined by the F test. 
Results
The normal concentration of epitestosterone in the blood of males and its dependence on age
The average concentration of epitestosterone, dihydrotestosterone and testosterone in the plasma of boys and men in various age groups from 6 to 65 years is given in figure 1 . In the case of all the observed Ci 9 -steroids there is a remarkable rise in the level in the course of puberty, and the highest average concentration is in the age group of 26-35 years, with the exception of epitestosterone, which maintains a practically constant level in all age groups after attaining adulthood. The lower concentration in the age group of men of 26-35 years may be due to the limited size of this age category. The increasing trend in puberty is most striking in testosterone, and least marked in epitestosterone. The course of age dependence of the average levels of epitestosterone is given in figure 2a , the median in figure 2b . The significance of the differences between the various age groups for epitestosterone is shown in table 2. The course of the ratios of concentration of epitestosterone to the concentration of testosterone depending on age is given in figure 3 .
The level of epitestosterone correlates positively with testosterone and with dihydrotestosterone (r = 0.586, p < 0.001, resp. r = 0.417, p < 0.001) and the ratio epitestosterone: testosterone correlates with age according to the equation y = 0.0875 + 36.8/x 2 (r = 0.759, p < 0.01). In childhood, at the age of 6 years the concentration of epitestosterone is on the average higher than the concentration of testosterone, later ratio changes exponentially in favour of testosterone and after puberty it remains practically constant with approximately ten times the amount of testosterone as compared with epitestosterone.
Concentration of epitestosterone in the tissue of hyperplastic prostate
The concentrations of epitestosterone, testosterone, dihydrotestosterone and androstenedione in the tissue samples taken from 15 men between the ages of 55-82 years are given in table 3. The average tissue concentration of epitestosterone is roughly twice as high as that of testosterone, half that of dihydrotestosterone and close to that of androstenedione.
Tab. 2 The significance of the difference in the plasma levels of epitestosterone between various age groups of men. 
NS -
The significance of differences between groups was tested with the + = significance level p < 0.05; t-test for different group variances. ++ = significance level p < 0.01; NS = not significant. The tissue concentration of epitestosterone correlates positively with age (r = 0.556, p < 0.05), and even closer is the correlation of the ratio epitestosterone: testosterone with age (r = 0.767, p < 0.01).
The tissue concentration of epitestosterone correlates linearly with the concentration of androstenedione (r = 0.634, p < 0.05) and dihydrotestosterone (r = 0.671, p < 0.05), but not with the concentration of testosterone.
Comparison of the concentrations of epitestosterone and androgenic steroids in the blood and in the prostate tissue
The ratio of epitestosterone: (testosterone + dihydrotestosterone) in the plasma was 0.08, whereas in the tissue of the hyperplastic prostate it amounted to an average value of 0.386.
Discussion
Epitestosterone in humans is not a metabolite of testosterone and its excretion is not dependent on the level of testosterone. Its biosynthesis takes place for the most part in the testicles, where its precursor is pregnenolone (17) . The production rate of epitestosterone is only 3% of the production rate of testosterone, but its excretion is about 1/3 of the excretion of testosterone (18) . As mentioned in the introduction, various experimental evidence has been brought so far concerning the anti-androgenic effect of epitestosterone in animals.
In humans we have documented the endogenous levels of epitestosterone in males during the life span, which has not been systematically studied. It has been found that in the course of sexual development there appears a marked change in the ratio of epitestosterone to testosterone. In pre-puberty epitestosterone predominates over testosterone, while in adult men approximately a ten times greater amount of testosterone occurs in the blood.
In men's hyperplastic prostate tissue epitestosterone is present in a concentration higher than testosterone, and approximates about half of that of dihydrotestosterone. In prostatic tissue in comparison with the blood the content of epitestosterone is relatively increased in contrast to androgens present. This is probably the result of different pharmacokinetics and pharmacodynamics of epitestosterone.
Provided that the binding to the receptor is comparable (for epitestosterone K] = 29.8 nmol/1, for dihydrotestosterone K! = 14.9 nmol/1 (6)), at least the same, or better, ten times higher concentrations of antagonists than those of agonists are necessary for evident antihormonal effects. Epitestosterone circulating in the blood in the pre-pubertal period approaches fulfillment of these conditions, and so does the tissue epitestosterone in the prostate of adult men. So it can be assumed that this steroid, long considered fully inactive, might act as an anti-androgen and as an inhibitor of 5 -reductase in the regulation of androgenization of the male organism during sexual maturation and in the regulation of androgen-dependent tissue processes, at least as their modulator.
Tab. 
Conclusion
Epitestosterone, an endogenous steroid, long considered biologically fully inactive, has a proven antiandrogenic effect and inhibits the biosynthesis of androgens. It has been documented that its concentration in the plasma of boys before puberty and the contents in the tissue of the hyperplastic prostate in men reaches values that can be assumed to counteract the effect of the androgens present.
